NTV Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $329K | Sell |
8,952
-300
| -3% | -$14.2K | 0.04% | 246 |
|
|
2025
Q4 | $471K | Hold |
9,252
| – | – | 0.05% | 211 |
|
|
2025
Q3 | $513K | Buy |
9,252
+46
| +0.5% | +$2.69K | 0.06% | 202 |
|
|
2025
Q2 | $635K | Sell |
9,206
-748
| -8% | -$50.9K | 0.08% | 169 |
|
|
2025
Q1 | $691K | Buy |
9,954
+748
| +8% | +$61.8K | 0.09% | 158 |
|
|
2024
Q4 | $792K | Buy |
9,206
+256
| +3% | +$27.7K | 0.1% | 136 |
|
|
2024
Q3 | $1.07M | Hold |
8,950
| – | – | 0.14% | 119 |
|
|
2024
Q2 | $1.28M | Hold |
8,950
| – | – | 0.18% | 98 |
|
|
2024
Q1 | $1.15M | Buy |
8,950
+1,650
| +23% | +$196K | 0.18% | 106 |
|
|
2023
Q4 | $755K | Sell |
7,300
-200
| -3% | -$19.8K | 0.13% | 130 |
|
|
2023
Q3 | $682K | Hold |
7,500
| – | – | 0.12% | 131 |
|
|
2023
Q2 | $607K | Sell |
7,500
-300
| -4% | -$24.5K | 0.11% | 141 |
|
|
2023
Q1 | $621K | Hold |
7,800
| – | – | 0.12% | 133 |
|
|
2022
Q4 | $528K | Hold |
7,800
| – | – | 0.1% | 141 |
|
|
2022
Q3 | $389K | Hold |
7,800
| – | – | 0.08% | 158 |
|
|
2022
Q2 | $435K | Hold |
7,800
| – | – | 0.09% | 159 |
|
|
2022
Q1 | $433K | Hold |
7,800
| – | – | 0.07% | 174 |
|
|
2021
Q4 | $437K | Sell |
7,800
-600
| -7% | -$32.5K | 0.07% | 168 |
|
|
2021
Q3 | $403K | Hold |
8,400
| – | – | 0.07% | 171 |
|
|
2021
Q2 | $352K | Hold |
8,400
| – | – | 0.06% | 182 |
|
|
2021
Q1 | $283K | Hold |
8,400
| – | – | 0.05% | 196 |
|
|
2020
Q4 | $293K | Hold |
8,400
| – | – | 0.06% | 171 |
|
|
2020
Q3 | $292K | Hold |
8,400
| – | – | 0.07% | 160 |
|
|
2020
Q2 | $275K | Hold |
8,400
| – | – | 0.07% | 157 |
|
|
2020
Q1 | $253K | Sell |
8,400
-400
| -5% | -$11.9K | 0.08% | 150 |
|
|
2019
Q4 | $255K | Hold |
8,800
| – | – | 0.07% | 156 |
|
|
2019
Q3 | $227K | Sell |
8,800
-400
| -4% | -$10.1K | 0.06% | 161 |
|
|
2019
Q2 | $235K | Hold |
9,200
| – | – | 0.07% | 163 |
|
|
2019
Q1 | $241K | Hold |
9,200
| – | – | 0.07% | 165 |
|
|
2018
Q4 | $212K | Hold |
9,200
| – | – | 0.07% | 165 |
|
|
2018
Q3 | $217K | Sell |
9,200
-1,200
| -12% | -$29.3K | 0.06% | 177 |
|
|
2018
Q2 | $240K | Hold |
10,400
| – | – | 0.07% | 165 |
|
|
2018
Q1 | $256K | Hold |
10,400
| – | – | 0.07% | 165 |
|
|
2017
Q4 | $279K | Sell |
10,400
-200
| -2% | -$5.09K | 0.08% | 156 |
|
|
2017
Q3 | $255K | Sell |
10,600
-1,400
| -12% | -$31.6K | 0.07% | 160 |
|
|
2017
Q2 | $257K | Sell |
12,000
-2,000
| -14% | -$40.4K | 0.08% | 159 |
|
|
2017
Q1 | $239K | Sell |
14,000
-800
| -5% | -$13.9K | 0.08% | 154 |
|
|
2016
Q4 | $265K | Sell |
14,800
-8,200
| -36% | -$149K | 0.09% | 144 |
|
|
2016
Q3 | $478K | Buy |
23,000
+1,000
| +5% | +$24.8K | 0.17% | 122 |
|
|
2016
Q2 | $591K | Buy |
22,000
+400
| +2% | +$11K | 0.22% | 105 |
|
|
2016
Q1 | $585K | Sell |
21,600
-1,000
| -4% | -$26.8K | 0.22% | 106 |
|
|
2015
Q4 | $656K | Hold |
22,600
| – | – | 0.26% | 100 |
|
|
2015
Q3 | $612K | Sell |
22,600
-1,000
| -4% | -$28.3K | 0.2% | 123 |
|
|
2015
Q2 | $646K | Buy |
23,600
+3,600
| +18% | +$101K | 0.19% | 130 |
|
|
2015
Q1 | $533K | Buy |
+20,000
| New | +$461K | 0.16% | 138 |
|
Other funds holding NVO
DAM
F
NTV Asset Management's NVO Position: Q1 2026 in Review
NTV Asset Management reduced its Novo Nordisk (NVO) stake by 3.2% in Q1 2026, selling an estimated $14.2K and leaving 8,952 shares worth $329K. The position accounts for 0.04% of the portfolio, ranked #246.
NTV Asset Management first reported a position in NVO in Q1 2015 and has held it in 45 quarters since. The position peaked at $1.28M in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- NTV Asset Management held 8,952 shares of Novo Nordisk worth $329K as of Q1 2026.
- NTV Asset Management sold 300 Novo Nordisk shares in Q1 2026, an estimated $14.2K.
- Novo Nordisk made up 0.04% of NTV Asset Management's portfolio in Q1 2026, its #246 holding.
- NTV Asset Management first reported a position in Novo Nordisk in Q1 2015 and has held it in 45 quarters since.
- NTV Asset Management's Novo Nordisk position peaked at $1.28M in Q2 2024.
- 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on NTV Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.